Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. B. van Etten

Publications

Comment on the RAPIDO Trial Point-Counterpoint Debate

Less pneumonia after nCRT and resection in oesophageal cancer using proton RT

Referral patterns of GIST patients: data from a nationwide study

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer

Authors' reply - A sensitivity analysis of the RAPIDO clinical trial

Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer?: No, it does not

Corrigendum to “Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not”: [ESMO Open 8 (2023) 101645]

Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue”: [Eur J Surg Oncol 49 (5) (May 2023) 974–982](S074879832300032X)(10.1016/j.ejso.2023.01.010)

Local recurrence in primary localised resected gastrointestinal stromal tumours: A registry observational national cohort study including 912 patients

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial

Read more

Press/media

Nieuwe behandeling van endeldarmkanker leidt tot minder uitzaaiingen